CDNA vs CELC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

CDNA

31.9
AI Score
VS
CELC Wins

CELC

53.0
AI Score

Investment Advisor Scores

CDNA

32score
Recommendation
SELL

CELC

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CDNA CELC Winner
Net Income -21.35M -131.71M CDNA
Operating Income -30.78M -116.63M CDNA
ROE -7.0% 1030.5% CELC
ROA -5.2% -15.9% CDNA
Total Assets 413.23M 828.22M CELC
Cash 65.43M 182.05M CELC
Current Ratio 2.86 8.93 CELC

Relative Price Performance (Last 90 Days)

CDNA 1M: +12.8% · 3M: +90.3% CELC 1M: -17.8% · 3M: -20.7%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.2% over 20 days), RSI 64

RSI (14): 63.9 · Price: $69.21

CELC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 42

RSI (14): 41.8 · Price: $65.25

Fundamentals Snapshot

Metric CDNA CELC
Market Cap — —
Forward P/E 53.7 -815.6
Trailing P/E 34.1 —
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.7% —
Operating Margin 0.0% 0.0%
EPS 2.03 -4.59
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CELC is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.